2025-01-15 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company providing a range of health benefits and services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 150.79%, while the VOO's cumulative return is 112.74%.  This represents a difference of 38.0 percentage points.  The relative divergence (30.2%) indicates that UNH's outperformance relative to its historical range against VOO is in the higher 30th percentile.


**2. Recent Price Movement:**

* **Closing Price:** $543.74
* **5-Day Moving Average:** $528.87
* **20-Day Moving Average:** $510.82
* **60-Day Moving Average:** $556.90

The current price is above the 5-day and 20-day moving averages, suggesting short-term upward momentum. However, it is below the 60-day moving average, indicating a potential short-term pullback from a recent higher price point.  The recent closing price may be indicative of a recent price increase or consolidation after a potentially volatile period.


**3. Technical Indicators and Expected Return:**

* **RSI:** 83.53 – This indicates the stock is in overbought territory, suggesting a potential short-term correction may be due.
* **PPO:** 1.28 – A positive value indicates bullish momentum.
* **Relative Divergence (20-day):** +13.4 – This shows a recent increase in the stock's relative strength compared to the benchmark.
* **Expected Return (2+ years):** 181.1% – This projects a significant outperformance compared to the S&P 500 over the long term, assuming continued positive momentum, but should be considered a high-risk projection.


**4. Recent Earnings Analysis:**

The earnings data shows some volatility.  While Q3 and Q4 2024 show strong EPS and revenue growth, Q2 2024's EPS shows a significant decline.  Further investigation is needed to understand the causes of this fluctuation, especially the substantial negative EPS in Q2 2024. Duplicate data points for 2024-11-04 need to be corrected.

| Date       | EPS    | Revenue (B$) |
|------------|--------|---------------|
| 2024-11-04 | 6.56   | 100.82        |
| 2024-08-09 | 4.58   | 98.86         |
| 2024-05-09 | -1.53  | 99.80         |
| 2023-11-06 | 6.31   | 92.36         |


**5. Financial Information:**

**Revenue and Profitability:** Revenue has remained relatively stable over the past year, with slight fluctuations quarter-to-quarter.  Profit margins have been consistently high, although there's a slight dip in the last two quarters.

| Quarter     | Revenue (B$) | Profit Margin |
|-------------|--------------|---------------|
| 2024-09-30  | $99.18       | 21.56%        |
| 2024-06-30  | $97.86       | 21.52%        |
| 2024-03-31  | $98.78       | 22.26%        |
| 2023-12-31  | $93.25       | 22.33%        |
| 2023-09-30  | $91.36       | 24.51%        |


**Capital and Profitability:** Equity has generally increased, but ROE shows significant volatility, with a negative value in Q1 2024.  This warrants further investigation into the underlying causes.

| Quarter     | Equity (B$) | ROE     |
|-------------|--------------|---------|
| 2024-09-30  | $94.53       | 6.41%   |
| 2024-06-30  | $89.36       | 4.72%   |
| 2024-03-31  | $86.69       | -1.63%  |
| 2023-12-31  | $88.76       | 6.15%   |
| 2023-09-30  | $84.49       | 6.91%   |


**7. Overall Summary:**

UNH has demonstrated strong historical outperformance compared to the S&P 500.  However, recent indicators (RSI) suggest the stock may be overbought in the short term.  The substantial negative EPS in Q2 2024 requires further analysis to understand the underlying reasons. While long-term projections indicate significant potential, investors should carefully consider the risks associated with the current overbought condition and the volatility in recent earnings and ROE.  The substantial projected long-term return should be approached with caution due to the inherent uncertainty of such projections.  Further due diligence, including examination of the company's future outlook and competitive landscape, is crucial before making any investment decisions.
